Reference: Weight regain after cessation of medication for weight management: systematic review and meta-analysis by Sam West, Jadine Scragg, Paul Aveyard, Jason L Oke, Lia Willis, Stella J P Haffner, Heather Knight, Danni Wang, Sarah Morrow, Laura Heath, Susan A Jebb and Dimitrios A Koutoukidis, 7 January 2026, BMJ
Effective long-term use of GLP-1RAs for obesity requires integrating symptom management, tailored nutrition, and structured physical activity to preserve muscle mass, prevent deficiencies, and support sustained weight loss
The targeted 3-PLG-ibu-A-GSH and ibuprofen at higher, 1.5 M concentration (the estimated drug content of the 3-PLG-ibu-A-GSH nanocarriers) significantly protected against the barrier damaging effect of cytokines with the ibuprofen-coupled targeted nanocarrier group showing the highest effect against BBB dysfunction (Fig
PREVENDM2: Prevencin de eventos cardiovasculares y enfermedad renal en la DM2 (2019-2020) con 11 crditos ECTS
